138 related articles for article (PubMed ID: 26059528)
21. Tumor-associated calcium signal transducer 2 regulates neovascularization of non-small-cell lung cancer via activating ERK1/2 signaling pathway.
Guo X; Zhu X; Zhao L; Li X; Cheng D; Feng K
Tumour Biol; 2017 Mar; 39(3):1010428317694324. PubMed ID: 28345466
[TBL] [Abstract][Full Text] [Related]
22. Advances in Trop2-targeted therapy: Novel agents and opportunities beyond breast cancer.
Liu X; Deng J; Yuan Y; Chen W; Sun W; Wang Y; Huang H; Liang B; Ming T; Wen J; Huang B; Xing D
Pharmacol Ther; 2022 Nov; 239():108296. PubMed ID: 36208791
[TBL] [Abstract][Full Text] [Related]
23. Epithelial cell adhesion molecule expression (CD326) in cancer: a short review.
Patriarca C; Macchi RM; Marschner AK; Mellstedt H
Cancer Treat Rev; 2012 Feb; 38(1):68-75. PubMed ID: 21576002
[TBL] [Abstract][Full Text] [Related]
24. ATF2 loss promotes tumor invasion in colorectal cancer cells via upregulation of cancer driver TROP2.
Huebner K; Erlenbach-Wuensch K; Prochazka J; Sheraj I; Hampel C; Mrazkova B; Michalcikova T; Tureckova J; Iatsiuk V; Weissmann A; Ferrazzi F; Kunze P; Nalli E; Sammer E; Gehring A; Cheema MM; Eckstein M; Paap EM; Soederberg A; Fischer C; Paul S; Mahadevan V; Ndreshkjana B; Meier MA; Muehlich S; Geppert CI; Merkel S; Grutzmann R; Roehe A; Banerjee S; Hartmann A; Sedlacek R; Schneider-Stock R
Cell Mol Life Sci; 2022 Jul; 79(8):423. PubMed ID: 35838828
[TBL] [Abstract][Full Text] [Related]
25. Metastasis-associated in colon cancer-1 and aldehyde dehydrogenase 1 are metastatic and prognostic biomarker for non-small cell lung cancer.
Zhou L; Yu L; Zhu B; Wu S; Song W; Gong X; Wang D
BMC Cancer; 2016 Nov; 16(1):876. PubMed ID: 27832750
[TBL] [Abstract][Full Text] [Related]
26. TROP2 is epigenetically inactivated and modulates IGF-1R signalling in lung adenocarcinoma.
Lin JC; Wu YY; Wu JY; Lin TC; Wu CT; Chang YL; Jou YS; Hong TM; Yang PC
EMBO Mol Med; 2012 Jun; 4(6):472-85. PubMed ID: 22419550
[TBL] [Abstract][Full Text] [Related]
27. CD133/CD166/Ki-67 triple immunofluorescence assessment for putative cancer stem cells in colon carcinoma.
Mărgaritescu C; Pirici D; Cherciu I; Bărbălan A; Cârtână T; Săftoiu A
J Gastrointestin Liver Dis; 2014 Jun; 23(2):161-70. PubMed ID: 24949608
[TBL] [Abstract][Full Text] [Related]
28. Impact of TROP2 expression on prognosis in solid tumors: A Systematic Review and Meta-analysis.
Zeng P; Chen MB; Zhou LN; Tang M; Liu CY; Lu PH
Sci Rep; 2016 Sep; 6():33658. PubMed ID: 27645103
[TBL] [Abstract][Full Text] [Related]
29. Targeting Trop2 in solid tumors: a look into structures and novel epitopes.
Liu X; Li J; Deng J; Zhao J; Zhao G; Zhang T; Jiang H; Liang B; Xing D; Wang J
Front Immunol; 2023; 14():1332489. PubMed ID: 38179054
[TBL] [Abstract][Full Text] [Related]
30. Trophoblast Cell Surface Antigen 2 Expression in Human Tumors: A Tissue Microarray Study on 18,563 Tumors.
Dum D; Taherpour N; Menz A; Höflmayer D; Völkel C; Hinsch A; Gorbokon N; Lennartz M; Hube-Magg C; Fraune C; Bernreuther C; Lebok P; Clauditz TS; Jacobsen F; Sauter G; Uhlig R; Wilczak W; Steurer S; Minner S; Marx AH; Simon R; Burandt E; Krech T; Luebke AM
Pathobiology; 2022; 89(4):245-258. PubMed ID: 35477165
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of p53 protein and MK-1 (a tumor-associated antigen) expression in gastric carcinoma.
Deveci MS; Deveci G
Gastric Cancer; 2007; 10(2):112-6. PubMed ID: 17577621
[TBL] [Abstract][Full Text] [Related]
32. Clinical significance of TROP2 expression in colorectal cancer.
Ohmachi T; Tanaka F; Mimori K; Inoue H; Yanaga K; Mori M
Clin Cancer Res; 2006 May; 12(10):3057-63. PubMed ID: 16707602
[TBL] [Abstract][Full Text] [Related]
33. Trophoblast cell-surface antigen 2 (TROP2) expression in triple-negative breast cancer.
Jeon Y; Jo U; Hong J; Gong G; Lee HJ
BMC Cancer; 2022 Sep; 22(1):1014. PubMed ID: 36153494
[TBL] [Abstract][Full Text] [Related]
34. Trop2 inhibition suppresses the proliferation and invasion of laryngeal carcinoma cells via the extracellular signal-regulated kinase/mitogen-activated protein kinase pathway.
Wang XD; Wang Q; Chen XL; Huang JF; Yin Y; Da P; Wu H
Mol Med Rep; 2015 Jul; 12(1):865-70. PubMed ID: 25779928
[TBL] [Abstract][Full Text] [Related]
35. (-)-Epigallocatechin-3-gallate (EGCG) post-transcriptionally and post-translationally suppresses the cell proliferative protein TROP2 in human colorectal cancer cells.
Sukhthankar M; Alberti S; Baek SJ
Anticancer Res; 2010 Jul; 30(7):2497-503. PubMed ID: 20682974
[TBL] [Abstract][Full Text] [Related]
36. Trop2 enhances invasion of thyroid cancer by inducing MMP2 through ERK and JNK pathways.
Guan H; Guo Z; Liang W; Li H; Wei G; Xu L; Xiao H; Li Y
BMC Cancer; 2017 Jul; 17(1):486. PubMed ID: 28709407
[TBL] [Abstract][Full Text] [Related]
37. [Role of TROP2 in cancer and as potential therapeutic target].
Huang HY
Zhonghua Bing Li Xue Za Zhi; 2013 Dec; 42(12):860-3. PubMed ID: 24507116
[No Abstract] [Full Text] [Related]
38. NDC80 promotes proliferation and metastasis of colon cancer cells.
Xing XK; Wu HY; Chen HL; Feng HG
Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27173328
[TBL] [Abstract][Full Text] [Related]
39. Variation of Trop2 on non-small-cell lung cancer and normal cell membranes revealed by super-resolution fluorescence imaging.
Fu Y; Jing Y; Gao J; Li Z; Wang H; Cai M; Tong T
Talanta; 2020 Jan; 207():120312. PubMed ID: 31594569
[TBL] [Abstract][Full Text] [Related]
40. Expression of serum amyloid A, in normal, dysplastic, and neoplastic human colonic mucosa: implication for a role in colonic tumorigenesis.
Gutfeld O; Prus D; Ackerman Z; Dishon S; Linke RP; Levin M; Urieli-Shoval S
J Histochem Cytochem; 2006 Jan; 54(1):63-73. PubMed ID: 16116035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
